Clinical trial
The Effect of CoQ10 Administration on Hemodialysis Patients
NCT00307996 · University of Shizuoka, Other · Completed
Key facts
| NCT number | NCT00307996 |
|---|---|
| Title | The Effect of CoQ10 Administration on Hemodialysis Patients |
| Official title | The Effect of CoQ10 Administration on the Oxidative and Antioxidative Markers in Hemodialysis Patients |
| Lead sponsor | University of Shizuoka, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Renal Failure, Hemodialysis |
| Intervention type | Drug |
| Interventions | Coenzyme Q10 (drug) |
| Enrollment | 40 |
| Start date | Mar 1, 2004 |
| Completion | Dec 1, 2004 |
| First posted | Mar 28, 2006 |
| Last update posted | Mar 28, 2006 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: